Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: differentiating pentameric and modified CRP isoform effects. | Front Immunol | 2023 | 37781355 | PubTator, text mining | PubMed |
| Comparison of oral cavity protein abundance among caries-free and caries-affected individuals-a systematic review and meta-analysis. | Front Oral Health | 2023 | 37780687 | PubTator, text mining | PubMed |
| Incorporation of Chitosan in Polyurethanes Based on Modified Castor Oil for Cardiovascular Applications. | Polymers (Basel) | 2023 | 37765587 | PubTator, text mining | PubMed |
| Progress in Regenerative Medicine: Exploring Autologous Platelet Concentrates and Their Clinical Applications. | Genes (Basel) | 2023 | 37761809 | PubTator, text mining | PubMed |
| Red Blood Cells from Individuals with Lesch-Nyhan Syndrome: Multi-Omics Insights into a Novel S162N Mutation Causing Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency. | Antioxidants (Basel) | 2023 | 37760001 | PubTator, text mining | PubMed |
| Trypanosomes and complement: more than one way to die? | Trends Parasitol | 2023 | 37758633 | PubTator, text mining | PubMed |
| Detection of N‑glycoprotein associated with IgA nephropathy in urine as a potential diagnostic biomarker using glycosylated proteomic analysis. | Exp Ther Med | 2023 | 37753295 | PubTator, text mining | PubMed |
| Structural biology of complement receptors. | Front Immunol | 2023 | 37753090 | PubTator, text mining | PubMed |
| Functional and structural analyses reveal that a dual domain sialidase protects bacteria from complement killing through desialylation of complement factors. | PLoS Pathog | 2023 | 37747935 | PubTator, text mining | PubMed |
| Modelling and analysis of the complement system signalling pathways: roles of C3, C5a and pro-inflammatory cytokines in SARS-CoV-2 infection. | PeerJ | 2023 | 37744234 | PubTator, text mining | PubMed |
| Comparing efficacies of autologous platelet concentrate preparations as mono-therapeutic agents in intra-bony defects through systematic review and meta-analysis. | J Oral Biol Craniofac Res | 2023 | 37711544 | PubTator, text mining | PubMed |
| Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis. | Ther Adv Musculoskelet Dis | 2023 | 37694182 | PubTator, text mining | PubMed |
| Oral microbiota in human health and disease: A perspective. | Exp Biol Med (Maywood) | 2023 | 37688509 | PubTator, text mining | PubMed |
Characterization of Leukocyte- and Platelet-Rich Plasma Derived from Female Collage Athletes: A Cross-Sectional Cohort Study Focusing on Growth Factor, Inflammatory Cytokines, and Anti-Inflammatory Cytokine Levels. | Int J Mol Sci | 2023 | 37686398 | PubTator, text mining | PubMed |
| Advances in Platelet Rich Plasma-Derived Extracellular Vesicles for Regenerative Medicine: A Systematic-Narrative Review. | Int J Mol Sci | 2023 | 37685849 | PubTator, text mining | PubMed |
| The Rationale of Complement Blockade of the MCPggaac Haplotype following Atypical Hemolytic Uremic Syndrome of Three Southeastern European Countries with a Literature Review. | Int J Mol Sci | 2023 | 37685848 | PubTator, text mining | PubMed |
| Deciphering complex breakage-fusion-bridge genome rearrangements with Ambigram. | Nat Commun | 2023 | 37684230 | PubTator, text mining | PubMed |
| A Review: Methodologies to Promote the Differentiation of Mesenchymal Stem Cells for the Regeneration of Intervertebral Disc Cells Following Intervertebral Disc Degeneration. | Cells | 2023 | 37681893 | PubTator, text mining | PubMed |
| Post-COVID symptoms are associated with endotypes reflecting poor inflammatory and hemostatic modulation. | Front Immunol | 2023 | 37680625 | PubTator, text mining | PubMed |
| Recruitment of C4b-binding protein is not a complement evasion strategy employed by Staphylococcus aureus. | Microbiology (Reading) | 2023 | 37668351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=10